Fully Built Ls Vtec 2000 Em1 Civic Custom Paint Job .. on 2040-cars

Auto blog

Honda thumbs nose at fleet sales, claims it leads in key vehicle segments

Fleet sales are a way of life in the automotive industry. There are many non-retail customers that need vehicles, but going too far can reduce brand image and vehicle resale value. While some of its competitors have fleet sale that account for up to 20 or 30 of overall sales, Honda is bragging that it has the lowest fleet sales of all mainstream automakers for the first five months of 2013.
After calculating new-car registration data from R.L. Polk, Honda says that just two percent of its sales through went to fleet customers compared to an industry average of 19 percent. Even though this means Honda leaves plenty of sales on the table each month, it also claims to have the highest resale value and lowest cost of ownership among its competitors. In terms of retail sales, Honda says that the Civic, Accord, CR-V and Odyssey all lead their respective segments, and it breaks down/brags about its retail sales success in the press release, which is posted below.

Honda Walking Assist Device begins US testing at Rehabilitation Institute of Chicago

For years, we've been wondering what implications Honda's Asimo robot could have in the real world, and now we're starting to get a sense of that. Honda announced that it will begin its first US clinical studies of the Walking Assist Device at the Rehabilitation Institute of Chicago in an effort to provided improved mobility for people who have suffered a stroke. While the automotive tie-in here is pretty weak, this is the first time we've heard about this device since it was unveiled back in 2008.
Weighing in at six pounds, Honda's device is fitted to the waist and legs of patients to make it easier to walk, and the 22.2-volt lithium-ion battery provides enough electricity for more than an hour of operation. According to Honda's press release, which is posted below, up to 80 percent of the almost 800,000 stroke victims each year (in the US alone) are afflicted with limited mobility, so a medical aid like this could have a big impact in the real world.

2014 Honda Accord V6 Touring

America's midsize sedan segment is one of the most crowded and fiercely competitive in the business. The Toyota Camry has long been our nation's best seller, while the Honda Accord has dutifully come in second place, like some sort of codependent Cal Naughton Jr. riding Ricky Bobby's back bumper.
There was that one year, 2001, when the Accord briefly broke the Camry's streak, marring what would today have been a 17-year-long run of best-selling car titles. The Accord pulled the opposite move in 2011, letting sales slip far enough to let not only the Toyota by, but the Nissan Altima and Ford Fusion, as well. Aside from those anomalies, the Camry and Accord have been first and second in this segment since before many of you readers could even drive.
It's 2014, and these frenemies have never before faced a threat to their world order as strong as today's class of family sedans. The aforementioned Altima and Fusion are perhaps the most capable challengers, but the Chevrolet Malibu, Hyundai Sonata, Kia Optima, Volkswagen Passat and Mazda6 are all capable of convincing new buyers to walk their way.